Immunome Appoints Phil Tsai as Chief Technical Officer
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
Immunome to Present at 2024 Bank of America Healthcare Conference
Immunome Appoints Kinney Horn as Chief Business Officer
Immunome Appoints Sandra M. Swain to Board of Directors
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
Immunome Completes Acquisition of AL102 From Ayala
Arrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies
Immunome to Participate in the Leerink Partners Global Biopharma Conference